Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study
Background: Familial hypercholesterolemia (FH) is predominantly caused by mutations in the 4 FH candidate genes (FHCGs), namely, low-density lipoprotein receptor (LDLR), apolipoprotein B-100 (APOB-100), proprotein convertase subtilisin/kexin type 9 (PCSK9), and the LDL receptor adaptor protein 1 (LD...
Similar Items
-
Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care
by: Kamal A.; Kanchau J.D.; Shahuri N.S.; Mohamed-Yassin M.-S.; Baharudin N.; Razak S.A.; Badlishah-Sham S.F.; Abdul-Hamid H.; Aziz A.F.A.; Al-Khateeb A.; Chua Y.A.; Kasim N.A.M.; Kadir S.H.S.A.; Nawawi H.; Qureshi N.; Ramli A.S.
Published: (2023) -
Homozygous familial hypercholesterolemia
by: Alicezah M.K.; Razali R.; Rahman T.; Hoh B.P.; Suhana N.H.; Muid S.; Nawawi H.M.; Koshy M.
Published: (2014) -
Health literacy in familial hypercholesterolemia: A cross-national study
by: Hagger M.S.; Hardcastle S.J.; Hu M.; Kwok S.; Lin J.; Nawawi H.M.; Pang J.; Santos R.D.; Soran H.; Su T.-C.; Tomlinson B.; Watts G.F.
Published: (2018) -
Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”
by: Pang J.; Chan D.C.; Hu M.; Muir L.A.; Kwok S.; Charng M.-J.; Florkowski C.M.; George P.M.; Lin J.; Loi D.D.; Marais A.D.; Nawawi H.M.; Gonzalez-Santos L.E.; Su T.-C.; Truong T.H.; Santos R.D.; Soran H.; Tomlinson B.; Yamashita S.; Ademi Z.; Watts G.F.
Published: (2019) -
Strategies for screening for familial hypercholesterolaemia in primary care and other community settings
by: Qureshi N.; Da Silva M.L.R.; Abdul-Hamid H.; Weng S.F.; Kai J.; Leonardi-Bee J.
Published: (2021)